Viewing Study NCT00284258


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2025-12-25 @ 9:56 PM
Study NCT ID: NCT00284258
Status: COMPLETED
Last Update Posted: 2012-11-02
First Post: 2006-01-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Sponsor: Taiho Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module